Drug Shortage Report for LIPITOR
| Report ID | 235514 |
| Drug Identification Number | 02243097 |
| Brand name | LIPITOR |
| Common or Proper name | ATORVASTATIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 3 x 10 BL |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-09-03 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2024-08-27 |
| Shortage status | Avoided shortage |
| Updated date | 2024-08-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-08-27 | French | Compare |
| v3 | 2024-08-27 | English | Compare |
| v2 | 2024-08-20 | French | Compare |
| v1 | 2024-08-20 | English | Compare |
Showing 1 to 4 of 4